1 |
To Investigate Growth Factor Receptor Targets and Generate Cancer
Targeting Inhibitors |
|
|
| Debroop Basu, Riya Pal, Maitrayee Sarkar, Soubhik Barma, Sumit Halder, Harekrishna Roy, Sisir Nandi, Asmita Samadder |
|
| Current Topics in Medicinal Chemistry. 2023; 23(30): 2877 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges |
|
|
| Anna Hau-Yee Kong, Aston Jiaxi Wu, Olivia Ka-Yi Ho, Maggie Ming-Ki Leung, Alexis Shiying Huang, Yuanyuan Yu, Ge Zhang, Aiping Lyu, Min Li, King-Ho Cheung |
|
| International Journal of Molecular Sciences. 2023; 24(14): 11780 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection |
|
|
| Esinam E. Agbosu, Scott Ledger, Anthony D. Kelleher, Jing Wen, Chantelle L. Ahlenstiel |
|
| Pharmaceutics. 2022; 14(7): 1352 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Radiation retinopathy intricacies and advances in management |
|
|
| Noraliz García-O’Farrill, Sangeethabalasri Pugazhendhi, Peter A. Karth, Allan A. Hunter |
|
| Seminars in Ophthalmology. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Identification of Key Genes and Pathways in Persistent Hyperplastic Primary Vitreous of the Eye Using Bioinformatic Analysis |
|
|
| Derin M. Thomas, Chitra Kannabiran, D. Balasubramanian |
|
| Frontiers in Medicine. 2021; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs) |
|
|
| Weina Ke, Kirill A. Afonin |
|
| Advanced Drug Delivery Reviews. 2021; 176: 113835 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Aptamers in biomedicine: Selection strategies and recent advances |
|
|
| Geanina ?tefan, Oana Hosu, Karolien De Wael, María Jesús Lobo-Castańón, Cecilia Cristea |
|
| Electrochimica Acta. 2021; 376: 137994 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review |
|
|
| Shibani Supe, Archana Upadhya, Kavita Singh |
|
| Experimental Eye Research. 2021; 202: 108329 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications |
|
|
| Hwankyu Lee |
|
| Pharmaceutics. 2020; 12(6): 533 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities |
|
|
| Fatemeh Farjadian, Amir Ghasemi, Omid Gohari, Amir Roointan, Mahdi Karimi, Michael R Hamblin |
|
| Nanomedicine. 2019; 14(1): 93 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy |
|
|
| Rui Zhang, Xin Sun, Bo Niu |
|
| Experimental and Therapeutic Medicine. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules |
|
|
| Marton, S., Reyes-Darias, J.A., Sánchez-Luque, F.J., Romero-López, C., Berzal-Herranz, A. |
|
| Molecules. 2010; 15(7): 4610-4638 |
|
| [Pubmed] [Google Scholar] |
|
13 |
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs |
|
|
| Grassi, M., Cavallaro, G., Scirč, S., Scaggiante, B., Dapas, B., Farra, R., Baiz, D., (...), Grassi, G. |
|
| Current Signal Transduction Therapy. 2010; 5(2): 92-120 |
|
| [Pubmed] [Google Scholar] |
|
14 |
Anti-vascular endothelial growth factor therapies for retinal vein occlusion | [Retina ven tikanikliǧinda anti-vasküler endotelyal büyüme faktörü tedavileri] |
|
|
| Güler, M., Yilmaz, T., Certel, I., Önder, H.I. |
|
| Retina-Vitreus. 2010; 18(1): 77-83 |
|
| [Pubmed] [Google Scholar] |
|
15 |
Use of pegaptanib in the treatment of vitreous haemorrhage in idiopathic retinal vasculitis |
|
|
| D Mitry,C Schmoll,V Hegde,S Borooah,J Singh,H Bennett |
|
| Eye. 2008; 22(11): 1449 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Use of pegaptanib in the treatment of vitreous haemorrhage in idiopathic retinal vasculitis |
|
|
| Mitry, D. and Schmoll, C. and Hegde, V. and Borooah, S. and Singh, J. and Bennett, H. |
|
| Eye. 2008; 22(11): 1449-1450 |
|
| [Pubmed] [Google Scholar] |
|
17 |
Current management of retinal vein occlusions |
|
|
| Colyer, M.H., Lai, M.M. |
|
| Techniques in Ophthalmology. 2008; 6(2): 53-59 |
|
| [Pubmed] [Google Scholar] |
|
18 |
Progress of the drug therapy in corneal neovascularization |
|
|
| Li, L., Xi, X.-H. |
|
| International Journal of Ophthalmology. 2008; 8(4): 807-809 |
|
| [Pubmed] [Google Scholar] |
|
19 |
Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis |
|
|
| Vianna, R.N.G., Squeri, G., Turquetti, R., Brasil, O.F.M., Burnier Jr., M.N. |
|
| Canadian Journal of Ophthalmology. 2008; 43(4): 492-493 |
|
| [Pubmed] [Google Scholar] |
|